U.S. markets close in 1 hour 44 minutes
  • S&P 500

    4,199.15
    +17.98 (+0.43%)
     
  • Dow 30

    34,155.08
    +280.23 (+0.83%)
     
  • Nasdaq

    13,920.29
    -42.39 (-0.30%)
     
  • Russell 2000

    2,281.39
    +14.95 (+0.66%)
     
  • Crude Oil

    64.49
    +0.91 (+1.43%)
     
  • Gold

    1,792.50
    +24.80 (+1.40%)
     
  • Silver

    27.02
    +1.15 (+4.43%)
     
  • EUR/USD

    1.2069
    +0.0046 (+0.39%)
     
  • 10-Yr Bond

    1.6100
    -0.0210 (-1.29%)
     
  • GBP/USD

    1.3912
    +0.0092 (+0.66%)
     
  • USD/JPY

    109.0630
    -0.2760 (-0.25%)
     
  • BTC-USD

    57,992.70
    +1,213.54 (+2.14%)
     
  • CMC Crypto 200

    1,429.22
    +35.56 (+2.55%)
     
  • FTSE 100

    6,969.81
    +8.33 (+0.12%)
     
  • Nikkei 225

    28,812.63
    -241.37 (-0.83%)
     

Lawsuits Filed Against LDOS, KRMD and EBS - Jakubowitz Law Pursues Shareholders Claims

  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
·3 min read
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.

NEW YORK, NY / ACCESSWIRE / May 3, 2021 / Jakubowitz Law announces that securities fraud class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies who purchased shares within the class periods listed below. Shareholders interested in representing the class of wronged shareholders have until the lead plaintiff deadline to petition the court. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff. For more details and to speak with our firm without cost or obligation, follow the links below.

Leidos Holdings, Inc. (NYSE:LDOS)

CONTACT JAKUBOWITZ ABOUT LDOS:
https://claimyourloss.com/securities/leidos-holdings-inc-loss-submission-form/?id=15412&from=1

Class Period: May 4, 2020 - February 23, 2021

Lead Plaintiff Deadline: May 3, 2021

The filed complaint alleges that defendants made materially false and/or misleading statements and/or failed to disclose that: (1) the purported benefits of the Company's acquisition of L3Harris' Security Detection & Automation businesses were significantly overstated; (2) Leidos' products suffered from numerous product defects, including faulty explosive detection systems at airports, ports, and borders; (3) as a result of the foregoing, the Company's financial results were significantly overstated; and (4) as a result of the foregoing, Defendants' positive statements about the Company's business, operations, and prospects were materially misleading and/or lacked a reasonable basis.

Repro Med Systems, Inc. (NASDAQ:KRMD)

CONTACT JAKUBOWITZ ABOUT KRMD:
https://claimyourloss.com/securities/repro-med-systems-inc-loss-submission-form/?id=15412&from=1

Class Period: August 4, 2020 - January 25, 2021

Lead Plaintiff Deadline: May 25, 2021

The filed complaint alleges that defendants made materially false and/or misleading statements and/or failed to disclose that: (1) starting in January 2020, Repro Med Systems ramped up the use of allowances, including growth rebates, to retain key customers and to incentivize growth; (2) as the rebates accrued, the Company's net sales were reasonably likely to decline; and (3) as a result of the foregoing, Defendants' positive statements about the Company's business, operations, and prospects were materially misleading and/or lacked a reasonable basis.

Emergent Biosolutions Inc. (NYSE:EBS)

CONTACT JAKUBOWITZ ABOUT EBS:
https://claimyourloss.com/securities/emergent-biosolutions-inc-loss-submission-form/?id=15412&from=1

Class Period: July 6, 2020 - March 31, 2021

Lead Plaintiff Deadline: June 18, 2021

The filed complaint alleges that defendants made materially false and/or misleading statements and/or failed to disclose that: (i) Emergent's Baltimore plant had a history of manufacturing issues increasing the likelihood for massive contaminations; (ii) these longstanding contamination risks and quality control issues at Emergent's facility led to a string of FDA citations; (iii) the Company previously had to discard the equivalent of millions of doses of COVID-19 vaccines after workers at the Baltimore plant deviated from manufacturing standards; and (iv) as a result of the foregoing, Defendants' public statements about Emergent's ability and capacity to mass manufacture multiple COVID-19 vaccines at its Baltimore manufacturing site were materially false and/or misleading and/or lacked a reasonable basis.

Jakubowitz Law is vigorous in pursuit of justice for shareholders who have been the victim of securities fraud. Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:
JAKUBOWITZ LAW
1140 Avenue of the Americas
9th Floor
New York, New York 10036
T: (212) 867-4490
F: (212) 537-5887

SOURCE: Jakubowitz Law



View source version on accesswire.com:
https://www.accesswire.com/644034/Lawsuits-Filed-Against-LDOS-KRMD-and-EBS--Jakubowitz-Law-Pursues-Shareholders-Claims